235
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Treatment of May–Thurner’s Syndrome and Associated Complications: A Multicenter Experience

, ORCID Icon, & ORCID Icon
Pages 4705-4710 | Published online: 20 Aug 2021

References

  • May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–427.
  • Virchow R. Uber die Erweinterung kleiner Gafassee. Arch Path Anat. 1851;3:427.
  • O’Sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823–836.
  • Thijs W, Rabe KF, Rosendaal FR, Middeldorp S. Predominance of left-sided deep vein thrombosis and body weight. J Thromb Haemost. 2010;8:2083–2084.
  • Peters M, Syed RK, Katz M, et al. May-Thurner syndrome: a not so uncommon cause of a common condition. Proc (Bayl Univ Med Cent). 2012;25:231–233.
  • Kim DOD, Porter DH. Venography anatomy, technique and interpretation. In: Kim DOD, editor. Peripheral Vascular Imaging and Intervention. Saint Louis, MO: Mosby-Year Book; 1992:269–349.
  • Knuttinen MG, Naidu S, Oklu R, et al. May-Thurner: diagnosis and endovascular management. Cardiovasc Diagn Ther. 2017;7:S159–S164.
  • Suwanabol PA, Tefera G, Schwarze ML. Syndromes associated with the deep veins: phlegmasia cerulean dolens, May-Thurner syndrome, and nutcracker syndrome. Perspect Vasc Surg Endovasc Ther. 2010;22:223–230.
  • Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2016;11(11):CD002783.
  • Sharifi M, Medhipour M, Bay C, Smith G, Sharifi J. Endovenous therapy for deep venous thrombosis: the TORPEDO trial. Catheter Cardiovasc Interv. 2010;76:316–325.
  • Sharifi M, Bay C, Medhipour M, et al. Thrombus obliteration by rapid percutaneous endovenous intervention in deep venous occlusion (TORPEDO) trial: midterm results. J Endovasc Ther. 2012;19:273–280.
  • Titus JM, Moise MA, Bena J, Lyden SP, Clair DG. Iliofemoral stenting for venous occlusive disease. J Vasc Surg. 2011;53:1138–1144.
  • Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377:2240–2252.
  • Mando R, Sigua-Arce P, Spencer L, Halalau A. Slippery stents: a case report and review of literature describing patients with May-Thurner syndrome that experienced stent migration. Case Rep Vasc Med. 2019;2019:7606727.
  • Elmahdy S, Shults CC, Moustafa MA. An unusual case of acute heart failure: a case report of iliocaval venous stent migration. J Investig Med High Impact Case Rep. 2018;6:1–3.
  • Birn J, Vedantham S. May-Thurner syndrome and other obstructive iliac vein lesions: meaning, myth, and mystery. Vasc Med. 2015;20:74–83.
  • Marston W, Fish D, Unger J, Keagy B. Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers. J Vasc Surg. 2011;53:1303–1308.
  • Kibbe MR, Ujiki M, Goodwin AL, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004;39:937–943.
  • Murphy EH, Davis CM, Journeycake JM, DeMuth RP, Arko FR. Symptomatic ileofemoral DVT after onset of oral contraceptive use in women with previously undiagnosed May-Thurner Syndrome. J Vasc Surg. 2009;49:697–703.
  • Oteros Fernandez R, Bravo Rodriguez F, Delgado Acosta F, Gonzalez Barrios I. [May-Thurner syndrome and surgery for scoliosis]. Radiologia. 2008;50:245–247. Portuguese
  • Kalu S, Shah P, Natarajan A, Nwankwo N, Mustafa U, Hussain N. May-Thurner syndrome: a case report and review of the literature. Case Re Vasc Med. 2013;2013:740182.
  • Kolber T, Lindh M, Akesson M, Wasselius J, Gottsater A, Ivancev K. Chronic iliac vein occlusion: midterm results of endovascular recanalization. J Endovasc Ther. 2009;16:483–491.
  • Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease CHEST guideline and expert panel report. Chest. 2016;149:315–352.
  • Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;14:e419S–e494S.
  • White JM, Comerota AJ. Venous compression syndromes. Vasc Endovasc Surg. 2017;5:155–168.
  • Mousa AY, Broce M, Yacoub M, AbuRahma AF. Iliac vein interrogation augments venous ulcer healing in patients who have failed standard compression therapy along with pathological venous closure. Ann Vas Surg. 2016;34:144–151.
  • Raju S, Davis M. Relative importance of iliac vein obstruction in patients with post-thrombotic femoral vein occlusion. J Vasc Surg Venous Lymphat Disord. 2014;2:107.
  • Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg. 2004;239:118–126.
  • Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during 2 years following dee vein thrombosis. J Thromb Haemost. 2008;6:1105–1112.
  • Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2016;11:CD002783.
  • Roy M, Sasson M, Rosales-Velderrain A, Moon S, Grove M, King T. Pharmacomechanical thrombolysis for deep vein thrombosis in may-thurner syndrome. Innovations. 2017;12:466–471.
  • Mickley V, Schwagierek R, Rillinger N, et al. Left iliac venous thrombosis caused by venous spur: treatment with thrombectomy and stent implantation. J Vasc Surg. 1998;28:492–497.
  • Oguzkurt L, Tercan F, Ozkan U, Gulcan O. Iliac vein compression syndrome: outcome of endovascular treatment with long-term follow-up. Eur J Radiol. 2008;68:487–492.
  • Zhang X, Shi X, Gao P, et al. Endovascular management of May-Thurner syndrome. Medicine. 2016;95:4.
  • Enden T, Haig Y, Kløw NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31–38.
  • Sharifi M, Bay C, Medhipour M, et al. Thrombus obliteration by rapid percutaneous endovenous intervention in deep venous occlusion (TORPEDO) trial: midterm results. J Endovasc Ther. 2012;19:273–280.
  • Enden T, Haig Y, Klow N, et al. Long-term outcome after additional catheter directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31–38.
  • Haig Y, Enden T, Slagsvold CE, et al. Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis. J Vasc Interv Radiol. 2012;24:17–24.
  • Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. Eur J Vasc Surg. 2002;24:209–214.
  • Comerota AJ, Kearon C, Gu CS, et al. Endovascular thrombus removal for acute iliofemoral deep vein thrombosis: analysis from a stratified multicenter randomized trial. Circulation. 2019;139:1162–1173.
  • Kahn SR, Partsch H, Vedantham S, Prandoni KC. Subcommittee on control of anticoagulation of the scientific and standardization committee of the international society on thrombosis and heamostasis. J Thromb Haemost. 2009;7(5):879.
  • Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007;46(5):979–990. doi:10.1016/j.jvs.2007.06.046
  • Moudgill N, Hager E, Gonsalves C, Larson R, Lombardi J, DiMuzio P. May-Thurner syndrome: case report and review of the literature involving modern endovascular therapy. Vascular. 2009;17:330–335.